What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Diabetes mellitus
Michael Roden mainly focuses on Internal medicine, Endocrinology, Insulin resistance, Type 2 diabetes and Diabetes mellitus.
His is involved in several facets of Endocrinology study, as is seen by his studies on Insulin, Skeletal muscle, Glycogen, Carbohydrate metabolism and Glucose tolerance test.
His research in Insulin intersects with topics in European Prospective Investigation into Cancer and Nutrition, Gluconeogenesis, Leptin and Diabetes risk.
Michael Roden works mostly in the field of Insulin resistance, limiting it down to topics relating to Mitochondrion and, in certain cases, Citric acid cycle, as a part of the same area of interest.
His biological study spans a wide range of topics, including Genetics, Obesity, Genome-wide association study, Adiponectin and Genetic association.
In his research, Linkage disequilibrium and Odds ratio is intimately related to Case-control study, which falls under the overarching field of Genome-wide association study.
His most cited work include:
- A genome-wide association search for type 2 diabetes genes in African Americans. (1727 citations)
- New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk (1707 citations)
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (1673 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Type 2 diabetes, Diabetes mellitus and Insulin resistance.
His research on Internal medicine often connects related topics like Type 1 diabetes.
His research is interdisciplinary, bridging the disciplines of Mitochondrion and Endocrinology.
His Type 2 diabetes research includes themes of Metformin, Inflammation, Glycemic and Type 2 Diabetes Mellitus.
His work deals with themes such as Gastroenterology, Heart rate variability, Cohort and Cardiology, which intersect with Diabetes mellitus.
His Insulin resistance research integrates issues from Lipid metabolism and Fatty liver.
He most often published in these fields:
- Internal medicine (74.19%)
- Endocrinology (57.97%)
- Type 2 diabetes (38.38%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (74.19%)
- Type 2 diabetes (38.38%)
- Endocrinology (57.97%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Type 2 diabetes, Endocrinology, Diabetes mellitus and Insulin resistance.
His Internal medicine research is multidisciplinary, incorporating elements of Type 1 diabetes and Cardiology.
His Type 2 diabetes research incorporates elements of Body mass index, Adiponectin, Glycemic and Type 2 Diabetes Mellitus.
His study in Adipose tissue, Steatosis, Carbohydrate metabolism, Glucose homeostasis and Lipolysis is carried out as part of his Endocrinology studies.
The Diabetes mellitus study combines topics in areas such as Heart rate variability, Disease, Recent onset and Intensive care medicine.
His Insulin resistance study integrates concerns from other disciplines, such as Skeletal muscle, Oxidative stress, Lipid metabolism and White adipose tissue.
Between 2017 and 2021, his most popular works were:
- The integrative biology of type 2 diabetes. (132 citations)
- Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract (116 citations)
- Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. (98 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Gene
His scientific interests lie mostly in Internal medicine, Diabetes mellitus, Type 2 diabetes, Insulin resistance and Endocrinology.
Michael Roden frequently studies issues relating to Gastroenterology and Internal medicine.
His research investigates the connection between Diabetes mellitus and topics such as Bioinformatics that intersect with issues in MEDLINE, Steatohepatitis, Metabolic syndrome and Disease.
His research integrates issues of Body mass index, Adiponectin, Pathogenesis and Type 2 Diabetes Mellitus in his study of Type 2 diabetes.
The concepts of his Insulin resistance study are interwoven with issues in Nonalcoholic fatty liver disease, Fatty liver, White adipose tissue and Weight loss.
Michael Roden works mostly in the field of Endocrinology, limiting it down to topics relating to Metabolomics and, in certain cases, LDL receptor, Sphingomyelin and Arginine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
